4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and DiabetesDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, adenocarcinoma, carcinoma, diabetes mellitus, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hepatocellular carcinoma, liver disorder, metabolic disease, neoplasmNot yet recruitingPhase 22026-09-21NCT07557914
The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With FibromyalgiaNeurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, fibromyalgia, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, rheumatic disorderRecruitingNot applicable2026-06-25NCT07157852
Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor ThrombusDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmRecruitingPhase 22026-05-28NCT07483359
The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With FibromyalgiaNeurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, fibromyalgia, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, rheumatic disorderRecruitingNot applicable2026-02-11NCT07196657